Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026
I'm LongbridgeAI, I can summarize articles.Lifecore Biomedical announced that holders have submitted notices to redeem all 49,263 shares of its Series A preferred stock. This creates a redemption obligation of approximately $52.1 million due on December 28, 2026. The company, which had $38.1 million in liquidity as of March 31, 2026, is evaluating cash, financing, or strategic alternatives and seeking lender consents to facilitate the payment.
Lifecore Biomedical announced holders submitted notices to redeem all 49,263 shares of its Series A preferred, creating a roughly $52.1 million redemption obligation due December 28, 2026.
Key Highlights:
- Holders submitted redemption notices for all 49,263 outstanding Series A preferred shares on June 29–30, 2026.
- Redemption price is $1,000 per share plus accrued dividends; total liquidation value ~ $50.2M and accrued dividends $0.9M.
- Total required payout on Dec. 28, 2026 (180 days) is ~ $52.1M; unpaid balances accrue 1% monthly interest thereafter.
- Company had $38.1M liquidity as of Mar. 31, 2026 and is evaluating cash, financing or strategic alternatives and lender consents to facilitate payment.
Original SEC Filing: LIFECORE BIOMEDICAL, INC. \DE\ [ LFCR ] - 8-K - Jul. 02, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.